Home

CHARLES L POPE

CIK 1136354 · Chief Executive Officer · last filed 2025-12-15

CHARLES L POPE is a Chief Executive Officer who has filed 52 SEC Form 4 insider transactions across 5 companies since 2009. The most recent filing, for OGEN, was dated Dec 15, 2025. Across all open-market trades the lifetime net is +$25.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $175.0K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$175.0K

Companies

5

Total Filings

52

Lifetime Open-Market Net

$25.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OGEN Director 849 $0.50 $422 -$31.1K 17 2025-12-15
MEDS Director 4,487 $3.55 $15.9K $0 2 2022-09-16
INUV Director 17,630 $0.96 $16.9K $31.5K 21 2018-07-03
INV Director 47,875 $2.96 $141.7K $0 3 2012-05-04
Inuvo, Inc. (KOW) Delisted Director 131,000 — — $24.9K 3 2009-07-27

Recent Filings

52 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-12-15 OGEN Grant (A) — $0 EDGAR
2024-09-20 OGEN Grant (A) — $0 EDGAR
2023-08-10 OGEN Grant (A) +25,000 $0 EDGAR
2022-09-16 MEDS Grant (A) +54,525 $0 EDGAR
2022-08-02 OGEN Grant (A) — $0 EDGAR
2021-12-17 OGEN Grant (A) — $0 EDGAR
2021-06-02 MEDS Grant (A) +10,912 $41.2K EDGAR
2021-02-19 OGEN Grant (A) — $0 EDGAR
2020-02-07 OGEN Grant (A) — $0 EDGAR
2019-06-24 OGEN Grant (A) — $0 EDGAR
Showing 1–10 of 52
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.